These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30968110)

  • 21. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
    Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
    Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera.
    Arifuzzaman M; Rashu R; Leung DT; Hosen MI; Bhuiyan TR; Bhuiyan MS; Rahman MA; Khanam F; Saha A; Charles RC; LaRocque RC; Weil AA; Clements JD; Holmes RK; Calderwood SB; Harris JB; Ryan ET; Qadri F
    Clin Vaccine Immunol; 2012 Aug; 19(8):1304-11. PubMed ID: 22739692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 25. An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.
    Kanungo S; Desai SN; Saha J; Nandy RK; Sinha A; Kim DR; Bannerjee B; Manna B; Yang JS; Ali M; Sur D; Wierzba TF
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003809. PubMed ID: 26023778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.
    Emch M; Ali M; Park JK; Yunus M; Sack DA; Clemens JD
    Int J Epidemiol; 2006 Aug; 35(4):1044-50. PubMed ID: 16723370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial.
    Fong Y; Halloran ME; Park JK; Marks F; Clemens JD; Chao DL
    BMC Infect Dis; 2018 Feb; 18(1):84. PubMed ID: 29463233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis.
    Khanam F; Kim DR; Liu X; Voysey M; Pitzer VE; Zaman K; Pollard AJ; Qadri F; Clemens JD
    EClinicalMedicine; 2023 Apr; 58():101925. PubMed ID: 37090439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to pay for oral cholera vaccines in urban Bangladesh.
    Sarker AR; Islam Z; Sultana M; Sheikh N; Mahumud RA; Islam MT; Meer RV; Morton A; Khan AI; Clemens JD; Qadri F; Khan JAM
    PLoS One; 2020; 15(4):e0232600. PubMed ID: 32353086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Khan AI; Ali M; Chowdhury F; Saha A; Khan IA; Khan A; Akter A; Asaduzzaman M; Islam MT; Kabir A; You YA; Saha NC; Cravioto A; Clemens JD; Qadri F
    Vaccine; 2017 Mar; 35(11):1538-1543. PubMed ID: 28196715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trial.
    Najnin N; Leder K; Qadri F; Forbes A; Unicomb L; Winch PJ; Ram PK; Leontsini E; Nizame FA; Arman S; Begum F; Biswas SK; Clemens JD; Ali M; Cravioto A; Luby SP
    Int J Epidemiol; 2017 Dec; 46(6):2056-2066. PubMed ID: 29025064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
    Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
    Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Islam MT; Chowdhury F; Qadri F; Sur D; Ganguly NK
    Vaccine; 2020 Feb; 38 Suppl 1():A127-A131. PubMed ID: 31301917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Hossain M; Tauheed I; Ahmed T; Islam S; Rafique TA; Siddique SA; Harun NB; Islam K; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007989. PubMed ID: 32176695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herd protection and herd amplification in cholera.
    Sack DA
    J Health Popul Nutr; 2006 Mar; 24(1):1-5. PubMed ID: 16796143
    [No Abstract]   [Full Text] [Related]  

  • 38. Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; Clemens JD; Raina MacIntyre C; Qadri F
    Vaccine; 2017 Sep; 35(37):5043-5049. PubMed ID: 28765003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future cholera vaccines.
    Shaikh H; Lynch J; Kim J; Excler JL
    Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
    Clemens JD; Sack DA; Harris JR; Van Loon F; Chakraborty J; Ahmed F; Rao MR; Khan MR; Yunus M; Huda N
    Lancet; 1990 Feb; 335(8684):270-3. PubMed ID: 1967730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.